Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy.
Hepatol Forum
; 3(3): 82-87, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36177099
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Hepatol Forum
Year:
2022
Document type:
Article
Country of publication: